Original article
The clinical impact of serum soluble CD25 levels in children with Langerhans cell histiocytosis
Zi-Jing Zhaoa,b,c, Hong-Yun Lianb,c,d, Wei-Jing Lia,b,c, Qing Zhanga,b,c, Hong-Hao Mab,c,d, Dong Wangb,c,d, Yun-Ze Zhaob,c,d, Ting Zhua,b,c, Hua-Lin Lia,b,c, Xiao-Tong Huanga,b,c, Tian-You Wangb,c,d, Rui Zhangb,c,d, Lei Cuia,b,c,∗, Zhi-Gang Lia,b,c,∗
a Hematologic Diseases Laboratory, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
b National Key Discipline of Pediatrics, Capital Medical University, Beijing, China
c Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China
d Department of Hematology, Hematology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
Read
1363
Timeswas read the article
405
Total PDF
958
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 7 | 30 | 22 | 52 |
| 2025 6 | 73 | 24 | 97 |
| 2025 5 | 62 | 19 | 81 |
| 2025 4 | 122 | 34 | 156 |
| 2025 3 | 239 | 48 | 287 |
| 2025 2 | 89 | 21 | 110 |
| 2025 1 | 51 | 31 | 82 |
| 2024 12 | 55 | 63 | 118 |
| 2024 11 | 50 | 40 | 90 |
| 2024 10 | 132 | 58 | 190 |
| 2024 9 | 55 | 45 | 100 |
